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Abstract 
The present study was designed to investigate the preventing effects of Urtica dioica (UD) against liver fibrosis 
and cirrhosis induced by carbon tetrachloride in male wistar rats. Cirrhosis is the final stage of chronic liver 
disease and leading cause of death worldwide. Urtica dioica is a medicinal plant with anti-inflammatory, anti-
allergic and anti-carcinogenic activities. The healthy age matched male wistar albino rats were used in the study. 
In this study 24 male albino wistar rats were divided in to four groups (n=6). Group I remained healthy control 
rats, group II , received CCl4 (0.8 ml/Kg b.w, s.c, for 8 weeks, twice a week), group III received CCl4 (0.8 
ml/Kg b.w, s.c, for 8 weeks, twice a week) together with UD(2 ml/kg UD extract i.p daily for 8 weeks), group 
IV received UD(2 ml/kg UD extract i.p daily for 8 weeks) . Biochemical analysis included total bilirubin, liver 
enzymes, antioxidant enzymes & MDA.The sixty day treatment of rats with CCl4 induced hepatotoxicity as 
indicated by enhanced liver enzymes, lipid peroxidation and decreased antioxidant enzyme levels in CCl4 
treated group compared with the control group. Urtica Dioica treatment for sixty days decreased hepatotoxic 
effects of CCl4 by significantly reducing the elevated liver enzyme, lipid peroxidation and raised the decreased 
antioxidant levels. The body weights of Group II,III &IV groups were reduced whereas maintained in group I.  
 
------------------------------------------------------------------------ 
* Corresponding author.  
E-mail address: lunasaf@yahoo.com. 
266 
 
International Journal of Sciences: Basic and Applied Research (IJSBAR) (2014) Volume 13, No  2, pp 266-279 
 
The histologic findings indicated portal and periportal fibrosis in CCl4 treated rats with 40% degenerative 
hepatocytes whereas UD treatment together with CCl4 indicated slight periportal fibrosis, fatty changes with no 
degenerative hepatocytes. 
Keywords: : Urtica dioica; hepatotoxicity; CCl4; cirrhosis; antioxidant  
1. Introduction  
Urtica Dioica (UD) or common nettle is a perennial herbaceous plant well known for stinging hair and belongs 
to family Urticaceae. It is abundant in northern Europe and much of Asia. Urtica Dioica is divided into six sub 
species almost with trichomes on the stem and leaves. Plant is consumed as a source of food, fiber and 
medicines in many countries especially in Turkey and China. Different parts of plant have been used 
traditionally for the treatment of arthritis, eczema, hemorrhoids, hyperthyroidism, bronchitis and cancer [1] 
Disorders of kidneys, urinary tract, GIT, locomotors system, CVS, Hemorrhage, flu, rheumatism and gout [2] A 
number of products such as steroids, terpenoids, and lectins and seven flavanol glycosides (Kaempherol-3-O-
glucoside and -3-O-rutinoside; quercitin -3-O-glucoside, and -3-O-rutinoside, isorhamnetin-3-O-glucoside, -3-
O-rutinoside and -3-Oneohesperidoside) have been isolated from different parts of plant. Various 
immunostimulatory, anti-carcinogenic, anti-inflammatory, antioxidant and anti-allergic properties of Flavonoid 
glycoside have been reported [3] Herbal Extracts of Urtica dioica are used as laxative, diuretic, and vermifuge 
conventionally in some countries. It is also used in antidandruff shampoo. The active ingredients of nettle leaf 
reduce TNF-α and inflammatory cytokines via inhibiting transcription factor required for the activation of TNF-
α and IL-1-β in the synovial tissue that lives the joint therefore used as an adjuvant remedy in arthritis patients 
[4,5,6] Urtica Dioica treatment has also been shown to provide symptomatic relief in benign prostrate 
hyperplasia [7,8] One of the active components of extract 3,4 divanillyl tetrahydrofuran has been shown to bind 
with sex hormone binding globulin thereby increasing free T2 concentration,  hence used by many body builders 
[9]. 
Liver Cirrhosis is a chief health issue especially in underdeveloped countries with low socio-economic range 
due to endemic hepatitis viral infections. It is also a major health problem in developed countries due to alcohol 
consumption. Hepatocytes carcinoma is the 5th most common cancer worldwide [10]. Carbon tetrachloride 
(CCl4) has been widely used to experimentally induce liver injury rodents. Carbon tetrachloride is oxidized to 
the trichloromethyl free radical, which ensures alkylation of proteins and DNA along with lipid peroxidation. 
Depletion of ATP precedes acute cytotoxicity. Carcinogenicity is observed on long-term, low dose exposure. 
Hepatic and renal toxicity are due to biotransformation of CCl4 to toxic metabolites. The toxic metabolites of 
CCl4 block formation and release of low-density lipoproteins and deplete hepatic stores of glutathione. In 
addition, a dramatic increase in calcium concentration occurs in hepatic mitochondria, accompanied by 
alterations in electrolyte distribution with swelling of hepatic cells and depletion of liver glycogen. Chronic 
exposure may result in fibrosis or cirrhosis. 
Use of herbal therapies have gained a lot of attention during these days and a number of herbs have been 
identified and used traditionally in different localities. Therefore this study was aimed to investigate the 
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hepatoprotective properties of Urtica dioica in the prevention of liver fibrosis and cirrhosis induced by CCl4 in 
rats.  
2. Materials & Methods 
24 male Albino wistar rats weighing 190-250g were purchased from the animal house of ICCBS (International 
center for chemical and biological sciences, Karachi, Pakistan) for the study. Animals were acclimatized to the 
laboratory conditions prior to the initiation of the experiment and caged in a quiet temperature controlled animal 
room (23+4ºC). Rats had free access to water and standard rat diet.  
2.1 Materials and extraction procedure 
UD seeds were purchased from a local herb store of Karachi, Pakistan. The seeds were powdered in a mixer and 
fixed oil of UD was extracted with the help of a rotary evaporator using diethyl ether as solvent. 
2.2 Ethical guidelines 
The experiments were conducted with ethical guidelines of institutional ERB (Ethical Review Board) and 
internationally accepted principles for laboratory use and care in animal research (Health Research Extension 
Act of 1985) 
2.3 Study design 
The rats were randomly divided in to four experimental groups, each of six rats. The experimental phase lasted 
for 60 days. CCl4 and other chemicals used in the present study were purchased from BDH laboratory supplies, 
Fisher Scientific UK limited and Fluka AG.  
Group I: Untreated control 
Group II: CCl4 treated 
Group III: CCl4 + UD treated 
Group IV: UD treated 
Group I served as control and received only 2 mL/kg normal saline solution for 60 days. Group II(CCl4 treated) 
& III(CCl4+UDtreated) received CCl4, 0.8 ml/kg of body weight, subcutaneously, twice a week for 60 days. 
Group III (CCl4 + UD treated) & IV(UD treated) received daily intra-peritoneal  injections of 2 mL/kg UD 
extract for 60 days. At 60th day rats of all groups were decapitated. The blood was collected from the neck 
wound in the lithium heparin coated tubes and centrifuged to collect plasma. Liver was excised, trimmed of 
connective tissues, rinsed with saline to eliminate blood contamination, dried by blotting with filter paper and 
weighed. The tissues then kept in freezer at -70 ºC until analysis.  
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2.4  Assessment of AST, ALT, ALP & Bilirubin  
Plasma ALT [11], AST[12], ALP [13] and total and direct bilirubin [14] were analyzed using commercially 
prepared reagent kits from Randox.  
2.5 Preparation of post mitochondrial supernatant 
Liver homogenate was prepared by taking 1gm of tissue in 10 ml of 5 mM potassium phosphate buffer (pH 7.8) 
by using a homogenizer. The homogenates then centrifuged at 800 g for 5minutes at 4°C to separate the nuclear 
debris. The supernatant so obtained was centrifuged at 10,500g for 20 minutes at 4°C to get post mitochondrial 
supernatant which was used to assay SOD, Catalase, MDA & glutathione reductase activity. 
2.6  Estimation of thiobarbituric acid substances:  
The malondialdehyde (MDA) content, a measure of lipid peroxidation, was assayed in in the form of 
thiobarbituric acid reacting substances (TBARS) by the lipid peroxidation method [15]. Briefly, the reaction 
mixture consisted of 0.2 ml of 8.1% sodium dodecyl sulphate, 1.5 ml of 20% acetic acid solution adjusted to pH 
3.5 with sodium hydroxide and 1.5 ml of 0.8% aqueous solution of thiobarbituric acid was added to 0.2 ml of 
10% (w/v) of PMS. The mixture was brought up to 4.0 ml with distilled water and heated at 95°C for 60 
minutes. After cooling with tap water, 1.0 ml distilled water and 5.0 ml of the mixture of n-butanol and pyridine 
(15:1 v/v) was added and centrifuged. The organic layer was taken out and its absorbance was measured at 532 
nm and compared with those obtained from MDA standards. The concentration values were calculated from 
absorption measurements as standard absorption.  
2.7  Estimation of catalase: 
Catalase activity was assayed by the method of Sinha [16]. Briefly the assay mixture consisted of 1.96 ml 
phosphate buffer (0.01M, pH 7.0), 1.0 ml hydrogen peroxide (0.2M) and 0.04 ml PMS (10% w/v) in a final 
volume of 3.0 ml. Then 2 ml dichromate acetic acid reagent was added in 1 ml reaction mixture, boiled for 10 
minutes & cooled. Changes in absorbance was recorded at 570nm.  
2.8  Estimation of superoxide dismutase: 
Superoxide Dismutase Levels in the cell free supernatant were measured by the method of [17]. Briefly 1.3 ml 
of solution A (0.1 ml EDTA containing 50 mM Na2CO3, pH 10.0), 0.5 ml of solution B (90 µm NBT nitro blue  
tetra zoliumdye) and 0.1 ml of solution C (0.6% Triton X-100 in solution A), 0.1 ml of solution D (20 mM 
Hydroxlamine hydrochloride, pH6.0) were mixed and the rate of NBT reduction was recorded for one minute at 
560 nm. 0.1 ml of the supernatant was added to the test cuvette as well as reference cuvette, which do not 
contain solution D. Finally, the percentage inhibition in the rate of reduction of NBT was recorded as described 
above. One enzyme unit was expressed as inverse of the amount of protein (mg) require in one minute.  
2.9  Estimation of glutathione reductase: 
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GSH activity was determined by continuous spectrophotometric rate determination [18]. In a clean glass test 
tube, 0.3 ml of 10% BSA, 1.5 ml of 50 mM potassium phosphate buffer( pH 7.6), 0.35 ml of 0.8 mM βNADPH 
and  0.1 ml of 30 mM oxidized glutathione was taken and finally added 0.1 ml of homogenate, mixed well by 
inversion. Absorbance was recorded at 340 nm at 25°C for 5 minutes on kinetic spectrophotometer PRIM 500 
(Germany) with automatic aspiration and thermostat. The activity was calculated using the molar coefficient for 
NADPH of 6.22 µmol ˉ ¹ x cm ˉ ¹ and expressed in unit/gram tissue.  
2.10   Histopathological examination  
Liver tissue samples were fixed with formalin and embedded in paraffin blocks, tissue then sectioned at 4µm 
and stained with eosine and hematotoxylin for microscopic examination. The degree of hepatic injury was 
evaluated from the histologic sections via gradings and numerical scores according to French. [19] 
Score 0 = no visible damage 
Score 1 = focal hepatocyte damage on less than 25% of the tissue 
Score 2 = focal hepatocyte damage on 25-50% of the tissue 
Score 3 = extensive, but focal hepatocyte lesion 
Score 4 = global hepatocyte necrosis 
2.11  Statistical analysis 
Results are presented as mean± standard deviation. Statistical significance and difference from control and test 
values were evaluated by Student’s t-test. Statistical probability of a= P<0.05, b= P<0.01, c= P<0.001 were 
considered to be significant.  
Table 1: Comparison of body weight, liver weight and relative liver weight in Control, CCl4 treated, CCl4 
+Urtica Dioica treated & Urtica Dioica treated groups 
 
CONTROL 
(n=6) 
CCL4 treated¹ 
(n=6) CCl4 + UD¹˒² (n=6) 
UD¹˒²˒³           
   (n=6) 
INITIAL BODY 
WEIGHT 214.66±4.50925 212.67±2.5166 209±3.605 200.33±0.5774 
FINAL BODY 
WEIGHT 237.33±11.1505 121.667±7.63ᵈ 186.33±2.0816ᵇ˒ᶜ 191±3.605 ᵇ˒ ᶜ˒ ⁿ 
LIVER WEIGHT 4.85±0.6403 7.42±1.4056 ᵅ 4.4±0.1ⁿ˒ᵅ 5.36±1.006ⁿ˒ᵅ˒ⁿ 
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RELATIVE 
LIVER WEIGHT  
(G LIVER/100 G 
BODY) 2.119±0.2444 6.486±1.411ᵇ 2.3611±0.0292ᵇ˒ᵅ 2.806±0.4946ⁿ˒ᵇ˒ⁿ 
The data is expressed as mean ± standard deviation.  
1= As compared with control 
2= As compared with CCl4 
3= As compared with CCl4+UD 
a= P<0.05, b= P<0.01, c= P<0.001, d=P<0.0001,  n= P>0.05(Non-significant) 
 
Table 2: Comparison of serum enzymes & Bilirubin levels in Control, CCl4 treated, CCl4 +Urtica Dioica 
treated & Urtica Dioica treated groups 
 
CONTROL 
(n=6) 
CCL4 treated¹ 
(n=6) CCl4 + UD¹˒² (n=6) 
UD¹˒²˒³           
   (n=6) 
AST (U/l) 8.5±0.212 25.16±5.48ᶜ 21.2±12.47ᵅ˒ⁿ 13.8±2.03ᵇ˒ⁿ˒ⁿ 
ALT (U/l) 17.5±3.27 24.62±3.68ᵇ 18.33±4.31ⁿ˒ᵅ 10.01±1.73ᵇ˒ᵈ˒ᵇ 
ALP (U/l) 290.70±111.43 683.56±219.52ᵇ 281.13±87.18ⁿ˒ᵇ 295.006± 45.13ⁿ˒ᵇ˒ⁿ 
BILIRUBIN 
(mg/dl) 0.4±0.0967 2.03±0.53ᶜ 0.55±0.306ⁿ˒ᵇ 1.08±0.38ᵇ˒ᵇ˒ᵅ 
 
The data is expressed as mean ± standard deviation.  
1= As compared with control 
2= As compared with CCl4 
3= As compared with CCl4+UD 
a= P<0.05, b= P<0.01, c= P<0.001, n= P>0.05(Non-significant) 
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Table 3: Comparison of liver antioxidant enzymes and MDA activity in control, CCl4 treated, CCl4 + Urtica 
Dioica treated & Urtica Dioica treated groups 
 
CONTROL CCl4¹ CCl4 + UD¹˒² UD¹˒²˒³ 
Catalase (µmol/g 
tissue) 17.31±2.18 4.831±0.68ᵇ 14.432±9.60ⁿ˒ᵇ 9.379±4.13ᵇ˒ᶜ˒ⁿ 
SOD  
(Unit/g tissue) 1.436±0.63 0.422±0.25ᵅ 1.473±0.61ⁿ˒ᵇ 1.219±0.46ⁿ˒ᵇ˒ⁿ 
GSH  
(Unit/g tissue) 0.811±0.08 0.0214±0.0015ᵈ 0.037±0.01ᵈ˒ᵅ 0.03±0.005ᵈ˒ᵇ˒ⁿ 
MDA  
(µmol/g tissue) 0.906±0.32 1.710±0.71ᵅ 1.35±0.18ᵅ˒ᵅ 0.98±0.14ⁿ˒ᵅ˒ᵇ 
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The data is expressed as mean ± standard deviation.  
1= As compared with control 
2= As compared with CCl4 
3= As compared with CCl4+UD 
a= P<0.05, b= P<0.01, c= P<0.001, n= P>0.05(Non-significant) 
 
 Table 4: Histopathological features in Control, CCl4 treated, CCl4 +Urtica dioica treated & Urtica dioica 
treated groups 
Histopathological findings CONTROL CCl4 CCl4 + UD UD 
Enlargement 0 0 0 0 
Paleness 0 0 0 0 
Fatty change 0 0 1 0 
Hydropic degeneration 0 0 0 0 
Portal inflammation 0 2 0 0 
Periportal inflammation 0 2 0 0 
portal fibrosis 0 2 0 0 
Periportal fibrosis 0 2 1 1 
Focal lobulitis 0 2 0 0 
Total Score  0 10 2 1 
Intracellular pigment deposition absent present absent absent 
Sinusoidal expansion absent absent absent absent 
Degenerative hepatocytes absent 30-40-% absent absent 
Ballooning degeneration absent absent absent absent 
Bile duct proliferation absent absent present absent 
Degree of hepatic injury is expressed as scores observed via light microscopy. Score 0 = no visible damage; 
Score 1 = focal hepatocyte damage on less than 25% of the tissue; Score 2 = focal hepatocyte damage on 25-
50% of the tissue;Score 3 = extensive, but focal hepatocyte lesion; Score 4 = global hepatocyte necrosis 
3. Results 
3.1 Effects of CCl4 and UD treatment on body & liver weight in control and treated rats 
Reduction in body weight and organ weight is a prominent feature of injury. Table-I compares the effects of 
Urtica dioica among control, CCl4 treated, CCl4 + U.D treated  & UD treated rats and shows that CCl4 
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administration significantly decreased body weight of animals as compared with control (P<0.0001). Urtica 
dioica treatment has shown to increase body weight significantly in U.D +CCl4 treated group as compared with 
CCl4 treated group (P<0.001). A significant increase in Liver weight (P<0.05) and relative liver weight 
(P<0.01) was observed in CCl4 treated group as compared with control whereas a significant reduction in liver 
weight (P<0.05) and relative liver weight (P<0.05) was noted in CCl4 + U.D treated rats as compared with 
CCl4. There is no significant change in liver weight (P>0.05) and relative liver (P>0.05) weight in UD treated 
rats and control.  
3.2 Effects of CCl4 and UD treatment on liver enzymes (ALT, AST, ALP) & Bilirubin in control and treated 
rats 
Table-II shows that levels of hepatic enzymes AST(P<0.001), ALT(P<0.01) & ALP(P<0.01) were raised 
significantly in CCl4 treated rats as compared with control. UD treatment has significantly reduced the enzymes 
ALT (P<0.05) & ALP(P<0.01) in CCl4 + U.D treated group as compared with CCl4 treated group whereas no 
significant change was observed in AST (P>0.05) in UD treated rats as compared with control.  Activities of 
AST, ALT &ALP were nearly similar in control group and UD treated group (P>0.05). Table-II shows that 
CCl4 treatment has significantly raised bilirubin level in rats as compared with control (P<0.001). Bilirubin 
concentration was reduced significantly (P<0.01) in CCl4 + U.D treated group as compared with CCl4 treated 
group. Bilirubin was significantly increased (P<0.01) in UD treated rats as compared with control.  
3.3 Effects of CCl4 and UD treatment on hepatic concentration of catalase in control and treated rats 
Table 3 shows significantly lower activities of catalase (P<0.0001) in CCl4 treated rats as compared with 
control.  UD treatment along with CCl4 has been shown to increase significantly the reduced activity of 
Catalase (P<0.01) in CCl4 + UD treated rats as compared to CCl4 treated group. Activity of catalase was 
significantly reduced in UD treated group (P<0.01) as compared with control.  
3.4 Effects of CCl4 and UD treatment on hepatic concentration of SOD in control and treated rats 
Activity of SOD was significantly reduced in CCl4 treated rats (P<0.05) as compared with control. Activity of 
SOD enhanced significantly in CCl4 + UD treated rats (P<0.01) as compared with CCl4 treated group.  SOD 
activity was nearly similar in UD treated rats and control and no significant change was observed (P>0.05) 
(Table 3). 
3.5 Effects of CCl4 and UD treatment on hepatic concentration of GSH in control and treated rats 
Activity of antioxidant enzyme Glutathione peroxidase was reduced significantly (P<0.0001)  in CCl4 treated 
rats as compared with control (Table 3). UD treatment along with CCl4 has been shown to increase significantly 
the reduced glutathione peroxidase activity (P<0.05) in CCl4 + UD treated rats as compared to CCl4 treated 
group. Activity of Glutathione peroxidase was significantly reduced in UD treated group(P<0.0001) as 
compared with control group (Table 3).  
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3.6 Effects of CCl4 and UD treatment on hepatic concentration of MDA in control and treated rats 
Table 3 shows that level of MDA was raised significantly (P<0.05) in CCl4 treated group as compared with 
control. UD treatment along with CCl4 has been shown to decrease significantly MDA level in CCl4 + UD 
treated (P<0.05) rats as compared with CCl4 treated group. MDA was not significantly changed in UD treated 
group (P>0.05) as compared with control.   
3.7 Histopathological findings 
Liver morphological changes were scored, described and summarized in Control, CCl4 treated, CCl4 +Urtica 
dioica treated & Urtica dioica treated groups (Table 1). No evident histological changes were observed in liver 
tissues of control group (Figure 1). Severe histopathological changes in CCl4 treated rat liver tissues were noted. 
The prominent changes include portal and periportal inflammation, portal and periportal fibrosis, focal lobulitis 
and intracellular pigment deposition . Degeneration of hepatocytes was also noted and degenerative hepatocytes 
constitute for 30-40% (Figure 2). Our experimental results showed that Urtica dioica treatment along with CCl4 
has partly improved and reversed the liver histological changes induced by CCl4 and slight and focal indications 
of periportal fibrosis, fatty changes and bile duct proliferation were found with apparently no degenerative 
hepatocytes (Figure 3). However enlargement, paleness, hydropic degeneration & dysplasia were absent in rat 
liver lobules of both CCl4 treated & CCl4 +Urtica dioica treated groups.  Hepatic architecture in UD treated 
group is similar to control group with no necrosis &degeneration. Only slight periportal fibrosis was noted in 
UD treated rat liver tissues (Figure 4) 
 
Figure I: Control 
 
 
Figure 2: CCl4 treated 
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Figure 3: CCl4 +Urtica treated 
 
 
Figure 4: Urtica treated 
 
4. Discussion 
In our study protective effects of Urtica dioica were investigated against hepatotoxicity induced by CCl4 in rats. 
CCl4 treatment has been shown to increase lipid peroxidation, liver enzymes and decrease antioxidant level 
(Table 2&3). CCl4 induces hepatotoxicity by altering permeability of plasma, mitochondrial and lysosomal 
membranes of hepatocytes that leads to cell damage as well as via production of reactive free radicals that 
further leads to cell destruction. In the present study hepatic enzymes AST, ALT, ALP and bilirubin were raised 
dramatically after CCl4 treatment (Table 2). Activities of  hepatic metabolic enzymes in plasma are indicators of 
liver functions and their elevated levels  reflects liver dysfunction as enzymes leak in to blood upon cell damage. 
On the other hand elevated serum bilirubin levels are indicative of potentially serious liver damage and loss of 
liver function. UD treatment along with CCl4 has been shown to decrease ALT, ALP & bilirubin concentration 
thereby suggesting its protective effects against liver damage (Table 2). AST level was not reduced significantly 
in our study (Table 2), as AST is found in most tissues of the body so is not a precise indicator of liver damage. 
Similar results are reported by other studies [20]. 
In our study activities of hepatic antioxidant enzymes catalase, superoxide dismutase and glutathione peroxidase 
were reduced in CCl4 treated rats (Table 3) this is because CCl4 causes production of reactive free radicals that 
induce damage through covalent binding to the membrane proteins and lipid peroxidation that further leads to 
oxidative destruction of cellular membranes [21]. Our experimental results showed that UD treatment 
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successively enhanced the hepatic antioxidant enzymes catalase, superoxide dismutase and glutathione 
peroxidase in CCl4 treated rats (Table 3). As oxidative stress plays a major role in tissue injury in a broad range 
of human diseases and antioxidants play key role in reducing, neutralizing and interfering with reactive oxygen 
species thereby reducing oxidative stress, thus it is reasonable to think that antioxidant properties of Urtica 
dioica are beneficial against hepatotoxicity created by CCl4 thereby preventing severe hepatic injury. Some 
studies also reported that UD has a powerful antioxidant activity [22]. Similarly one study reported that UD is 
effective against iron promoted oxidation of phospholipids, linoleic acids and deoxyribose. In the present study 
MDA concentration was greatly increased after CCl4 treatment in rats. MDA is a specific indicator of lipid 
peroxidation formed via degradation of polyunsaturated lipids by reactive oxygen species that readily attack 
polyunsaturated fatty acids of cell membrane thereby initiating a self-propagating chain reaction that ends at 
destruction of membrane lipids.  In our study UD treatment reduced hepatic MDA level suggesting its 
preventive potential against lipid peroxidation and subsequent cellular degradation. Our results are confirmed by 
other studies which reported that Urtica dioica prevent damage of rat liver tissue structure. The histological 
findings reported in this study are in accordance with the biochemical results. Hepatotoxicity induced by CCl4 is 
confirmed by histological changes in liver tissues which indicated portal and periportal inflammation and 
fibrosis with intracellular pigment deposition and hepatocyte degeneration. Similar changes in liver tissues were 
noted by [8]. Our experimental results showed that Urtica dioica treatment along with CCl4 has partly improved 
and reversed the liver histological changes induced by CCl4 and slight and focal indications of periportal 
fibrosis, fatty changes and bile duct proliferation were found with apparently no degenerative hepatocytes. 
Similar histological features were reported by [23]. 
5. Conclusion  
Liver cirrhosis is a major health problem with increased morbidity and mortality. Use of 
 herbal therapies is a current matter of interest among researchers for the prevention and treatment of diseases 
including liver cirrhosis. This study suggests that herbal extract of Urtica Dioica can be beneficial in the 
prevention and treatment of hepatotoxicity created by CCl4 thus more research work is required to elaborate the 
medicinal properties of Urtica dioica and on the other hand awareness about the usefulness of this herb should 
be disseminated among people.  
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